SNWVHealthcare · Medical DevicesTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 49 of 100 as at 1 Aug 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores SANUWAVE Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (100): The business earns solid, repeatable profits on what it owns.
Momentum (4): The shares have been drifting down relative to others.
The rank is the raw material. Whether the rules would actually own SANUWAVE Health, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on SNWV, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 30 Mar 2026 | Roth Capital | Reiterates | Buy | $53 → $47 |
| 3 Sept 2025 | Northland Capital Markets | Initiates | Outperform | — |
| 22 Aug 2025 | Roth Capital | Maintains | Buy | — |
| 29 July 2025 | Roth Capital | Initiates | Buy | — |
| 15 Sept 2020 | Lake Street | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 64% of US stocks
Cheaper than 66% of US stocks
Cheaper than 4% of US stocks
Cheaper than 35% of US stocks
Higher than 37% of US stocks
Higher than 40% of US stocks
Higher than 89% of US stocks
Higher than 25% of US stocks
Higher than 93% of US stocks
Higher than 99% of US stocks
Higher than 91% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SNWV appears on the weeks it earns a place.
Sanuwave Health, Inc. announced it will host a conference call on August 7, 2026, at 8:30 AM ET to present its second-quarter 2026 financial results.
Why it matters — The call will provide investors and stakeholders with the company's latest quarterly financial performance and business update.
Of the 1 analysts covering SANUWAVE Health, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SANUWAVE Health, Inc. 49 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, SANUWAVE Health, Inc. ranks 49 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (100 of 100).
No analyst covering SANUWAVE Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SNWV are extrapolating price history, which says nothing about the business.
SANUWAVE Health, Inc. returned -82.6% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Sanuwave Health Inc. is an innovative company within the medical technology sector, focusing primarily on the development and commercialization of non-invasive, shockwave-based devices for a variety of medical conditions.
The most recent item we track (GlobeNewsWire, 30 July 2026): "Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results". Sanuwave Health, Inc. announced it will host a conference call on August 7, 2026, at 8:30 AM ET to present its second-quarter 2026 financial results.
Sanuwave Health Inc. is an innovative company within the medical technology sector, focusing primarily on the development and commercialization of non-invasive, shockwave-based devices for a variety of medical conditions. The company's flagship products are designed to promote healing in soft tissue and bone through its proprietary, high-energy, and low-energy pressure waves. These devices find applications in wound healing, particularly in chronic and diabetic ulcers, as well as in orthopedic conditions, broadening their reach across healthcare markets. Sanuwave Health Inc.'s technologies hold significance for improving patient outcomes, reducing healing times, and minimizing the need for more invasive procedures. Headquartered in Alpharetta, Georgia, the company continues to impact the medical industry by driving advancements in regenerative medicine solutions through its innovative approaches.
CEO Mr. Morgan C. Frank · 55 employees · United States · https://sanuwave.com